CSIMarket


Gilead Sciences Inc   (GILD)
Other Ticker:  
 

Gilead Sciences Inc

GILD's Fundamental analysis








Looking into Gilead Sciences Inc growth rates, revenue grew by 5.26 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1369

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -0.98 %

Gilead Sciences Inc faced net loss in contrast to the net income a year ago in I. Quarter 2024

More on GILD's Growth


Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Gilead Sciences Inc realized cash outflow of $ -0.17per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
179.64
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.96.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.65.


More on GILD's Valuation
 
 Total Debt (Millions $) 25,194
 Dividend TTM ($) 3.05 $
 Dividend Yield TTM (%) 4.89 %
 Revenue/Employee (TTM) $ 1,906,250
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.98
 Tangible Book Value (Per Share $) -11.46

Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Gilead Sciences Inc realized cash outflow of $ -0.17per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
179.64
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.96.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.65.

Gilead Sciences Inc Price to Book Ratio is at 4.65 lower than Indusry Avg. of 751.9. and higher than S&P 500 Avg. of 0.01

More on GILD's Valuation

  Market Capitalization (Millions $) 81,130
  Shares Outstanding (Millions) 1,247
  Employees 14,400
  Revenues (TTM) (Millions $) 27,450
  Net Income (TTM) (Millions $) 458
  Cash Flow (TTM) (Millions $) -218
  Capital Exp. (TTM) (Millions $) -581
  Total Debt (Millions $) 25,194
  Dividend TTM ($) 3.05 $
  Dividend Yield TTM (%) 4.89 %
  Revenue/Employee (TTM) $ 1,906,250
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 5.98
  Tangible Book Value (Per Share $) -11.46

  Market Capitalization (Millions $) 81,130
  Shares Outstanding (Millions) 1,247
  Employees 14,400
  Revenues (TTM) (Millions $) 27,450
  Net Income (TTM) (Millions $) 458
  Cash Flow (TTM) (Millions $) -218
  Capital Exp. (TTM) (Millions $) -581





  Ratio
   Capital Ratio (MRQ) 1.08
  Total Debt to Equity (MRQ) 1.44
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.45
  Inventory Turnover Ratio (TTM) 3.83





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com